Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & GamblefiledCriticalProcter & Gamble
Priority claimed from PCT/US1996/004954external-prioritypatent/WO1996032115A1/en
Publication of MXPA97007810ApublicationCriticalpatent/MXPA97007810A/en
Publication of MX9707810ApublicationCriticalpatent/MX9707810A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
This invention is a pharmaceutical composition that inhibits the growth of cancers and tumors in mammals, particularly in human and warm blooded animals. The composition is also effective against viruses. The composition contains N-phosphonoglycine derivatives which are systemic herbicides. The composition can also contain N-phosphonoglycine derivatives in combination with chemotherapeutic agents for treatment of cancers and tumors. Optionally potentiators can be included. N-phosphonoglycine derivatives with a potentiator can be used to treat viral infections.
MX9707810A1995-08-031996-04-11A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers.
MX9707810A
(en)
A pharmaceutical composition containing N-chlorophenyl carbamates, N-chlorophenylthiocarbamates and N-phosphonoglycine derivatives for inhibiting the development of viruses and cancers in mammals.
Pharmaceutical compositions containing 1,2,4-benzotriazine 1,4-dioxide and use thereof for the preparation of pharmaceutical compositions treating cancer
A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals.